Recent Updates
Recently added Catalysts
XLO Positive Sentiment Score: 70/100

Xilio Therapeutics to Present at Morgan Stanley 21st Annual Global Healthcare Conference

Tuesday, September 5, 2023 1 min read
Key Takeaway: Xilio Therapeutics, a clinical-stage biotechnology company focused on immuno-oncology therapies, announced its participation in the Morgan Stanley 21st Annual Global Healthcare Conference. CEO Renée Russo will engage in a fireside chat scheduled for September 11, 2023. The event underscores the company's commitment to showcasing its innovations in cancer treatment and fostering investor relations. A live webcast of the chat will be available on Xilio's website, along with a replay for 30 days post-event.

Market Sentiment Analysis

POSITIVE FACTORS

  • Xilio Therapeutics is participating in a significant industry conference.
  • The presentation highlights the company's efforts in developing cancer therapies.
  • The CEO's involvement indicates strong leadership and engagement with investors.

Full Press Release Details

WALTHAM, Mass., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that René Russo, Pharm.D., chief executive officer, will participate in a fireside chat at the Morgan Stanley 21st Annual Global Healthcare Conference on Monday, September 11, 2023, at 2:55 pm EST.
A live webcast can be accessed under “Events & Presentations” in the Investors & Media section of the Xilio Therapeutics website at https://ir.xiliotx.com/. A replay of the webcast will be archived on the website for 30 days following the presentation.
About Xilio Therapeutics
This press release contains hyperlinks to information that is not deemed to be incorporated by reference in this press release.
For Investor and Media Inquiries:
Head of Investor Relations and Corporate Communications
investors@xiliotx.com
Xilio@argotpartners.com

Frequently Asked Questions

When will Xilio Therapeutics participate in the conference?

Xilio Therapeutics will participate on September 11, 2023, at 2:55 pm EST.

Who will represent Xilio at the Morgan Stanley conference?

René Russo, Pharm.D., the CEO of Xilio Therapeutics, will represent the company.

Where can I access the live webcast of the event?

The live webcast can be found in the 'Events & Presentations' section on their website.

How long will the webcast replay be available?

The webcast replay will be available for 30 days after the presentation.

What is Xilio Therapeutics focused on developing?

Xilio Therapeutics is focused on tumor-activated immuno-oncology therapies for cancer.

Tags: XLO Viatris Investor Conferences Healthcare Xilo Therapeutics Morgan Stanley global healthcare conference immuno-oncology cancer therapies
Last updated: Sep 5, 2023